Business Wire National BioTech News
- Saskatchewan Celebrates Science During Global Biotech Week - September 27 to October 3, 2021
- Ventus Therapeutics to Present Data for Novel Peripherally Restricted and Brain-Penetrant NLRP3 Small Molecule Inhibitors for the Treatment of Inflammatory and Neurological Diseases
- Appili Therapeutics Announces Last Patient Enrolled in Phase 3 Trial of Oral Avigan®/Reeqonus™ for the Treatment of Mild-to-Moderate COVID-19
- BELLUS Health Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Refractory Chronic Cough and BLUEPRINT Phase 2a Trial for Chronic Pruritus Associated with Atopic Dermatitis
- Celltrion Awarded up to $626 Million From the Department of Defense to Supply COVID-19 Point-of-Care (POC) Rapid Antigen Test Kits
- FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market Maker
- AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies
- Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development
- Investable Universe Launches Provocative Polar Futures Media Series
- Life Sciences Stakeholders Launch Collaboration to Advance Inclusion, Diversity, Equity and Accessibility (IDEA)